Delivery Order SPE2DB20D2014-SPE2DB25FA91J

Award Date 1/29/25
Potential Completion Date 1/30/25
Potential Value $4.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The $4,396.10 firm fixed-price contract is for the delivery of VERQUVO 10 MG TABLET 30S, a pharmaceutical product, to support federal healthcare programs. The award has an ultimate completion date of November 19, 2024 and was issued on November 18, 2024. This contract is not...
This federal contract award, valued at $1,354.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VERQUVO 2.5 MG TABLET 30S, a pharmaceutical product, and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,766.15 firm fixed-price delivery order is for the supply of the medication VERQUVO 2.5 MG TABLET 30S, with a completion date of December 9, 2024. The award is not designated as a set-aside contract. It appears to be part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,276.35 firm fixed-price delivery order is for the supply of 30-tablet packages of the medication Verquvo 5 mg. The contract has an ultimate completion date of November 29, 2024 and was awarded on November 27, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award, valued at $1,087.74, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications,...
This federal contract award, with ID SPE2DB22D3102|SPE2DB25FK9LT, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,079.12 firm fixed-price delivery order is for the supply of 4566873886 VERQUVO 5 MG TABLET 30S, a pharmaceutical product. The award has an ultimate completion date of January 9, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product VERQUVO 10 MG TABLET 30S. The contract has a ceiling value of $4,910.41 and a period of performance through July 18, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract to provide the specified medication to support military treatment programs and facilities. The contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $11,921.19 firm-fixed-price contract is for the delivery of the medication VERQUVO 10 MG TABLET 90S. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA to provide a comprehensive range of pharmaceutical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,912.92, is for the supply of VERQUVO 2.5 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 31, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there are no set-aside requirements indicated for this award. The...
This federal contract award is a Delivery Order (SPE2DB22D1202|SPE2DB25FUKU4) placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,260.04 Firm Fixed Price contract is for the delivery of the pharmaceutical product VERQUVO 2.5 MG TABLET 30S. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FA91J
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,928.77 firm fixed-price delivery order is for the supply of VERQUVO 10 MG TABLET 90S, a medication, to support military healthcare programs.

The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. This IDC, which runs through November 2026, encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and there are no major subcontractors mentioned.

Generated 5/4/25, 12:43 AM